Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 246
Signaling pathways in obesity: mechanisms and therapeutic interventions
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 231
Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
Maddalena Grieco, Alessandra Giorgi, Maria Cristina Gentile, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 170
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 78
GLP-1a: Going beyond Traditional Use
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 70
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
En-Hao Hu, Ming‐Lung Tsai, Yuan Lin, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 357-357
Open Access | Times Cited: 18
Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy
Maria Grazia Rossino, Massimo Dal Monte, G. Casini
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 81
Fecal fermentation and high-fat diet-induced obesity mouse model confirmed exopolysaccharide from Weissella cibaria PFY06 can ameliorate obesity by regulating the gut microbiota
Yinzhuo Xie, Fangyi Pei, Yuchao Liu, et al.
Carbohydrate Polymers (2023) Vol. 318, pp. 121122-121122
Closed Access | Times Cited: 26
Signatures of metabolic diseases on spermatogenesis and testicular metabolism
David F. Carrageta, Sara Pereira, Rita Ferreira, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 477-494
Closed Access | Times Cited: 12
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Rafael Tamayo‐Trujillo, Viviana A. Ruiz‐Pozo, Santiago Cadena-Ullauri, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 12
Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
Joanna Michałowska, Ewa Miller‐Kasprzak, Paweł Bogdański
Nutrients (2021) Vol. 13, Iss. 2, pp. 351-351
Open Access | Times Cited: 48
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Jan Detka, Katarzyna Głombik
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 47
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 19
Hypothalamic Supramammillary Control of Cognition and Motivation
Andrew J. Kesner, Marjan Mozaffarilegha, Keerthi Thirtamara Rajamani, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7538-7546
Open Access | Times Cited: 19
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
Angelo Maria Patti, Rosaria Vincenza Giglio, Alberto Allotta, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1362-1362
Open Access | Times Cited: 17
The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade
Noha F. Hassan, Diaa Ragab, Shaimaa G. Ibrahim, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112308-112308
Closed Access | Times Cited: 7
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
Wael Halloum, Yousef Al Dughem, Dagmar Beier, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Wen-Xin Ping, Shan Hu, Jingqian Su, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 361-377
Open Access | Times Cited: 6
Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
Ahmed Elsanhoury, Vivian Nelki, Sebastian Kelle, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 40
Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics
Liliane El Eid, Christopher A. Reynolds, Alejandra Tomás, et al.
Pharmacological Research (2022) Vol. 184, pp. 106411-106411
Open Access | Times Cited: 25
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 14
Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention
Rebeca Ortega, Bo Liu, Shanta J. Persaud
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10777-10777
Open Access | Times Cited: 14
The nucleus accumbens shell: a neural hub at the interface of homeostatic and hedonic feeding
A Marinescu, Marie A. Labouesse
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Unlocking the Multifaceted Roles of GLP-1: Physiological Functions and Therapeutic Potential.
Tohada M. AL‐Noshokaty, Rehab Abdelhamid, Nourhan M. Abdelmaksoud, et al.
Toxicology Reports (2025) Vol. 14, pp. 101895-101895
Open Access
In vitro cellular model systems provide a promising alternative to animal experiments for studying the intestine-organ axis
Alessandra Vitale, Cristiana De Musis, Marida Bimonte, et al.
Critical Reviews in Biotechnology (2025), pp. 1-18
Open Access
Page 1 - Next Page

Scroll to top